FADD and lung carcinoma: The phosphorylation status of FADD does not seem to affect apoptosis and has also been related with poor prognosis in lymphomas and lung cancer via NF-kB-cyclin D1 activation [11,12]; nevertheless, its impact on HNSCC is controversial [13].